Cargando…
MiR-29b/TET1/ZEB2 signaling axis regulates metastatic properties and epithelial-mesenchymal transition in breast cancer cells
MiR-29b has been reported to be both a suppressor and a promoter in breast cancer (BC) cells proliferation and metastasis. Significant efforts have been made to explain the seemingly contradictory effects of miR-29b on BC, but no answer has yet been clearly verified. In this study, we overexpressed...
Autores principales: | Wang, Hua, An, Xinglan, Yu, Hao, Zhang, Sheng, Tang, Bo, Zhang, Xueming, Li, Ziyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731940/ https://www.ncbi.nlm.nih.gov/pubmed/29254230 http://dx.doi.org/10.18632/oncotarget.22183 |
Ejemplares similares
-
miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
por: GUO, FEI, et al.
Publicado: (2014) -
LINC01296/miR-141-3p/ZEB1-ZEB2 axis promotes tumor metastasis via enhancing epithelial-mesenchymal transition process
por: Sun, Zhenqiang, et al.
Publicado: (2021) -
The VIM-AS1/miR-655/ZEB1 axis modulates bladder cancer cell metastasis by regulating epithelial–mesenchymal transition
por: Xiong, Yaoyao, et al.
Publicado: (2021) -
Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis
por: Dong, P, et al.
Publicado: (2013) -
Effect of TET inhibitor on bovine parthenogenetic embryo development
por: Zhang, Jian, et al.
Publicado: (2017)